Additionally, Foxp3 alone is not always sufficient to correctly identify Tregs (25), suggesting that a range of markers and higher dimensional approaches (such as UMAP) are needed to fully separate Tregs from non-Tregs in the context of the aggressive cellular activation seen in COVID-19 patients. Here, FOXP3 is linked to COVID-19.